85 related articles for article (PubMed ID: 8373205)
1. [Immunological effects of locoregional immunochemotherapy for liver metastases of gastric cancer].
Sugiyama Y; Kato M; Takao H; Kida H; Kunieda K; Umemoto T; Miya K; Azuma S; Furuta T; Saji S
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1461-4. PubMed ID: 8373205
[TBL] [Abstract][Full Text] [Related]
2. [Locoregional therapy for liver metastases of colorectal cancer].
Sugiyama Y; Saji S; Miya K; Fukada D; Umemoto T; Kunieda K; Takao H; Kato M; Kawai M
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1433-6. PubMed ID: 8854772
[TBL] [Abstract][Full Text] [Related]
3. [Significance of antitumor effects and immunological response on endogenously induced LAK therapy for primary or metastatic liver tumor].
Miya K; Saji S; Furuta T; Azuma S; Umemoto T; Takao H; Katou M; Kanno A; Kaneda N; Yamawaki Y
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1453-6. PubMed ID: 1530292
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic effect of transarterial infusion immunochemotherapy for metastatic liver cancer].
Miya K; Saji S; Furuta T; Tanemura H; Azuma S; Umemoto T; Kunieda K; Takao H; Sugiyama Y; Kawai M
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1992-5. PubMed ID: 1908665
[TBL] [Abstract][Full Text] [Related]
5. Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.
Yamaguchi Y; Ohshita A; Kawabuchi Y; Hihara J; Miyahara E; Noma K; Toge T
Int J Oncol; 2004 Apr; 24(4):959-66. PubMed ID: 15010836
[TBL] [Abstract][Full Text] [Related]
6. [Effects of OK-432 intraportal administration on cell-mediated immune responses].
Minamimura T; Katsuyama S; Yamasaki K; Ookami H; Okamoto M; Masuyama K; Yamamoto K; Takemori S; Arai H; Sakamoto T; Tazawa K; Fujimaki M
Gan To Kagaku Ryoho; 1997 Sep; 24(12):1867-9. PubMed ID: 9382553
[TBL] [Abstract][Full Text] [Related]
7. [Intraarterial combination immunotherapy in hepatocellular carcinoma].
Hazama S; Oka M; Shimizu R; Yano K; Yoshino S; Iizuka N; Murakami T; Suzuki T
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1638-42. PubMed ID: 2167639
[TBL] [Abstract][Full Text] [Related]
8. Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver.
Zaloudik J; Lauerova L; Janakova L; Talac R; Simickova M; Nekulova M; Mikulikova I; Kovarik J; Sheard M
Hepatogastroenterology; 1999; 46(25):220-7. PubMed ID: 10228796
[TBL] [Abstract][Full Text] [Related]
9. [Improved therapeutic effect of sequential immunotherapy with cyclophosphamide, large doses of OK-432 and recombinant interleukin-2 in breast cancer patients with disseminated metastatic liver tumors].
Akimoto M; Nishihira T; Hirakawa H; Abe M; Ohuchi N; Mori S; Kumagai K
Nihon Geka Gakkai Zasshi; 1991 Jan; 92(1):64-74. PubMed ID: 2014029
[TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation of intermittent hepatic arterial infusion therapy for metastatic liver tumor of gastric and colorectal cancer].
Miya K; Adachi T; Nagao N; Takagi Y; Kawaguchi Y; Kato M; Takao H; Sugiyama Y; Kunieda K; Umemoto T; Fukada D; Saji S
Gan To Kagaku Ryoho; 1998 Jul; 25(9):1397-401. PubMed ID: 9703838
[TBL] [Abstract][Full Text] [Related]
11. The increase of CD57+ T cells in the peripheral blood and their impaired immune functions in patients with advanced gastric cancer.
Chochi K; Ichikura T; Majima T; Kawabata T; Matsumoto A; Sugasawa H; Kawarabayashi N; Takayama E; Hiraide H; Seki S; Mochizuki H
Oncol Rep; 2003; 10(5):1443-8. PubMed ID: 12883721
[TBL] [Abstract][Full Text] [Related]
12. Alterations in tumor necrosis factor-alpha, interferon-gamma, and interleukin-6 production by natural killer cell-enriched peripheral blood mononuclear cells in chronic alcoholism: relationship with liver disease and ethanol intake.
Laso FJ; Lapeña P; Madruga JI; San Miguel JF; Orfao A; Iglesias MC; Alvarez-Mon M
Alcohol Clin Exp Res; 1997 Oct; 21(7):1226-31. PubMed ID: 9347083
[TBL] [Abstract][Full Text] [Related]
13. Elimination of established liver metastases by human interleukin 2-activated natural killer cells after locoregional or systemic adoptive transfer.
Okada K; Nannmark U; Vujanovic NL; Watkins S; Basse P; Herberman RB; Whiteside TL
Cancer Res; 1996 Apr; 56(7):1599-608. PubMed ID: 8603408
[TBL] [Abstract][Full Text] [Related]
14. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
Gaddy J; Broxmeyer HE
Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743
[TBL] [Abstract][Full Text] [Related]
15. An in vitro Shwartzman reaction-like response is augmented age-dependently in human peripheral blood mononuclear cells.
Motegi A; Kinoshita M; Sato K; Shinomiya N; Ono S; Nonoyama S; Hiraide H; Seki S
J Leukoc Biol; 2006 Mar; 79(3):463-72. PubMed ID: 16387840
[TBL] [Abstract][Full Text] [Related]
16. Combined antitumour activity of mitomycin C, 5-fluorouracil and interleukin-2 against human colon cancer cells.
Ishihara M; Kubota T; Watanabe M; Kawano Y; Narai S; Yasui N; Otani Y; Teramoto T; Kitajima M
Anticancer Res; 1999; 19(1A):313-6. PubMed ID: 10226560
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical characterisation of immunological changes at the tumour site after chemo-immunotherapy with doxorubicin, interleukin-2 and interferon-gamma.
Lumsden AJ; Codde JP; Van der Meide PH; Gray BN
Anticancer Res; 1996; 16(3A):1145-54. PubMed ID: 8702226
[TBL] [Abstract][Full Text] [Related]
18. Effect of streptococcal lyzate OK-432 on peripheral blood mononuclear cells in gastric cancer patients.
Nakayama F; Iwagaki H; Gouchi A; Hizuta A; Isozaki H; Takakura N; Tanaka N
J Med; 1998; 29(3-4):199-215. PubMed ID: 9865458
[TBL] [Abstract][Full Text] [Related]
19. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells.
Takahashi E; Kuranaga N; Satoh K; Habu Y; Shinomiya N; Asano T; Seki S; Hayakawa M
Scand J Immunol; 2007 Feb; 65(2):126-38. PubMed ID: 17257217
[TBL] [Abstract][Full Text] [Related]
20. [Clinical studies on locoregional immunochemotherapy of peritonitis carcinomatosa].
Sugiyama Y; Saji S; Furuta T; Azuma S; Miya K; Umemoto T; Takao H; Kato M; Kanno A
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1724-7. PubMed ID: 1530341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
